NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,237,451 | +8.0% | 51,418 | +7.0% | 0.16% | +5.4% |
Q2 2023 | $4,850,706 | +24.4% | 48,070 | +13.4% | 0.15% | +10.4% |
Q1 2023 | $3,899,601 | +19.8% | 42,398 | +18.2% | 0.14% | +0.7% |
Q4 2022 | $3,254,943 | +33.8% | 35,879 | +12.1% | 0.13% | +21.8% |
Q3 2022 | $2,433,000 | -6.9% | 32,003 | +3.5% | 0.11% | -9.1% |
Q2 2022 | $2,613,000 | +42.5% | 30,915 | +47.8% | 0.12% | +36.0% |
Q1 2022 | $1,834,000 | +76.9% | 20,915 | +76.3% | 0.09% | +45.9% |
Q4 2021 | $1,037,000 | +29.3% | 11,861 | +20.9% | 0.06% | -15.3% |
Q3 2021 | $802,000 | -10.9% | 9,811 | -0.5% | 0.07% | -23.4% |
Q2 2021 | $900,000 | -16.6% | 9,862 | -21.9% | 0.09% | -42.3% |
Q1 2021 | $1,079,000 | -23.7% | 12,623 | -15.8% | 0.16% | -47.1% |
Q4 2020 | $1,415,000 | +8.8% | 14,987 | +0.3% | 0.31% | -15.6% |
Q3 2020 | $1,300,000 | +14.6% | 14,946 | +15.1% | 0.36% | -29.0% |
Q2 2020 | $1,134,000 | +30.8% | 12,986 | +23.5% | 0.51% | +1.6% |
Q1 2020 | $867,000 | – | 10,514 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |